Phase 1/2 inhalation clinical study of Ampligen
Latest Information Update: 02 Jun 2021
At a glance
- Drugs Rintatolimod (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors AIM ImmunoTech
- 02 Jun 2021 New trial record